tiprankstipranks
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
PremiumThe FlyHutchmed divests 45% interest in Shanghai Hutchison for $608M
9d ago
HUTCHMED Sells Major Stake to Focus on Core Business
Premium
Company Announcements
HUTCHMED Sells Major Stake to Focus on Core Business
9d ago
HUTCHMED Expands Brokerage Partnerships in London
Premium
Company Announcements
HUTCHMED Expands Brokerage Partnerships in London
10d ago
HUTCHMED’s Lung Cancer Therapy Gains Breakthrough Status
PremiumCompany AnnouncementsHUTCHMED’s Lung Cancer Therapy Gains Breakthrough Status
29d ago
Hutchmed announces Elunate, Tyvyt NDA granted approval in China
Premium
The Fly
Hutchmed announces Elunate, Tyvyt NDA granted approval in China
1M ago
HUTCHMED Gains Approval for Innovative Cancer Therapy
Premium
Company Announcements
HUTCHMED Gains Approval for Innovative Cancer Therapy
1M ago
HUTCHMED China Announces Diverse Board Leadership
PremiumCompany AnnouncementsHUTCHMED China Announces Diverse Board Leadership
2M ago
HUTCHMED Appoints Experienced Director to Board
Premium
Company Announcements
HUTCHMED Appoints Experienced Director to Board
2M ago
Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
Premium
The Fly
Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100